Novavax reports Covid vaccine is more than 90% effective in late-stage trial

It also performed well against emerging variants of the deadly virus.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.